Home Cart 0 Sign in  
X

[ CAS No. 56908-88-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 56908-88-4
Chemical Structure| 56908-88-4
Chemical Structure| 56908-88-4
Structure of 56908-88-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 56908-88-4 ]

Related Doc. of [ 56908-88-4 ]

Alternatived Products of [ 56908-88-4 ]

Product Details of [ 56908-88-4 ]

CAS No. :56908-88-4 MDL No. :MFCD00052415
Formula : C7H5Br3 Boiling Point : -
Linear Structure Formula :- InChI Key :PWTFRUXTAFBWBW-UHFFFAOYSA-N
M.W : 328.83 Pubchem ID :143427
Synonyms :

Calculated chemistry of [ 56908-88-4 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 54.68
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.57 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.78
Log Po/w (XLOGP3) : 3.86
Log Po/w (WLOGP) : 3.95
Log Po/w (MLOGP) : 4.53
Log Po/w (SILICOS-IT) : 4.19
Consensus Log Po/w : 3.86

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.69
Solubility : 0.00674 mg/ml ; 0.0000205 mol/l
Class : Moderately soluble
Log S (Ali) : -3.56
Solubility : 0.0913 mg/ml ; 0.000278 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.33
Solubility : 0.00153 mg/ml ; 0.00000466 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.99

Safety of [ 56908-88-4 ]

Signal Word:Danger Class:8,4.1
Precautionary Statements:P210-P240-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403-P501 UN#:2921
Hazard Statements:H228-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 56908-88-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 56908-88-4 ]
  • Downstream synthetic route of [ 56908-88-4 ]

[ 56908-88-4 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 56908-88-4 ]
  • [ 56990-02-4 ]
YieldReaction ConditionsOperation in experiment
92% With 4-methylmorpholine N-oxide In tetrahydrofuran for 12 h; Reflux A solution of compound C (3.29 g, 10 mmol) and 4-methyl-n-oxo morpholine (3.51 g, 30 mmol) were dissolved in 60 mL of tetrahydrofuran and the reaction mixture was heated under reflux for 12 hours. The organic compound was dried over magnesium sulfate and dried over silica gel column chromatography using dichloromethane / petroleum ether (v / v = 2: 3) as eluent. After drying and steaming, the mixture was dried to give the intermediate D (2.42 g, yield 92percent) as a white solid.
Reference: [1] Patent: CN106946777, 2017, A, . Location in patent: Paragraph 0063-0065
  • 2
  • [ 145691-59-4 ]
  • [ 56908-88-4 ]
YieldReaction ConditionsOperation in experiment
2.5 g With carbon tetrabromide; triphenylphosphine In dichloromethane at 20℃; for 1 h; General procedure: 3,5-Di-t-butylbenzoic acid (5.00 g, 0.021 mol) was dissolved in anhydrous THF (250 mL) under argon atmosphere and the solution cooled to 0 °C. Lithium aluminum hydride (1.62 g, 0.043 mol) was added in small portions and the solution stirred at room temperature overnight. The reaction was quenched with water, Et2O (100 mL) was added and the mixture acidified with concentrated HCl solution until the solid residue was dissolved. The medium was extracted with Et2O and the organic phase dried over MgSO4, filtered and concentrated to yield 4.31g of 5a. 1H NMR δ (CDCl3) 1.34 (s, 18H, di-t-butyl), 4.70 (s, 2H, PhCH2OH), 7.23 (d, 2H, J = 1.8 Hz, 2-CH and 6-CH), 7.38 (t, 1H, J = 1.8 Hz, 4-CH). Crude alcohol 5a (4.25 g) was dissolved in anhydrous CH2Cl2 (500 mL) and cooled at 0 °C. Triphenylphosphine (10.23 g, 0.039 mol) and carbon tetrabromide (12.93 g, 0.039 mol) were added and the mixture was stirred at room temperature for 1 h. The reaction mixture was quenched with water and extracted with CH2Cl2. The organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography on silica gel with hexanes to yield 4.62 g (86percent) of bromide 5b.
Reference: [1] Chemistry - A European Journal, 2012, vol. 18, # 24, p. 7473 - 7485
[2] European Journal of Organic Chemistry, 2007, # 16, p. 2700 - 2712
[3] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1215 - 1227
[4] European Journal of Medicinal Chemistry, 2011, vol. 46, # 9, p. 4227 - 4237
  • 3
  • [ 1611-92-3 ]
  • [ 56908-88-4 ]
YieldReaction ConditionsOperation in experiment
74% With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane for 24 h; Reflux 1,3-dibromo-5-toluene (4.96 g, 20 mmol) was dissolved in 150 ml of tetrachloromethane and then benzoyl peroxide (0.36 g, 1.5 mmol) and N-bromosuccinimide (3.74 g, 21 mmol) was added thereto, and the reaction mixture was heated under reflux for 24 hours. The reaction solution was then poured into water and extracted with methylene chloride. The organic compound was dried over magnesium sulfate and treated with dichloromethane / petroleum ether (v / v = 2: 3) was chromatographed on silica gel as a eluent, dried and steamed to give intermediate C (4.87 g, 74percent yield) as a white solid.
48.3% With N-Bromosuccinimide; dibenzoyl peroxide In hexane; benzene Referential Example 22
Production of 3,5-Dibromobenzyl Bromide
3,5-Dibromotoluene (27.0 g; 108.0 mmol), N-bromosuccinimide (19.2 g; 108.0 mmol), and benzoyl peroxide (0.32 g) were added to benzene (200 ml), and the mixture was refluxed for 2.5 hours.
The mixture was brought to room temperature, and the solvent was evaporated under reduced pressure.
The residue was taken up in n-hexane (200 ml), and the mixture was left to stand overnight at room temperature.
Crystals that precipitated were filtered off, and the filtrate was concentrated under reduced pressure, to thereby yield 17.2 g of the target compound (yield: 48.3percent).
1H-NMR (CDCl3, ppm); 4.36 (2H, s), 7.47 (2H, d, J=1.62 Hz), 7.60 (1H, t, J=1.62 Hz).
44% With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane; hexane 3,5-dibromobenzyl bromide
3,5-dibromotoluene (78.92 g, 0.316 mole) was dissolved in 1.27 L of carbon tetrachloride; to this solution was added N-bromosuccinimide (61.65 g, 0.346 mole) at room temperature.
A portion of dibenzoyl peroxide (0.6 g, 0.008 equivalents) was added and the solution heated to reflux temperature for 2.5 hours.
The reaction mixture was cooled to room temperature, filtered and the solvent removed in vacuo to yield a solid.
The solid was dissolved in 200 mL of warm hexane, filtered and cooled to room temperature.
Crystallizations ensued; the crystals were filtered off and washed with cold hexane and air dried to give 45.15 g (44percent) of 3,5-dibromobenzyl bromide. 1 H-NMR(CDCl3); δ 7.6 (1H), 7.47 (2H), 4.36 (2H).
Reference: [1] Patent: CN106946777, 2017, A, . Location in patent: Paragraph 0060-0062
[2] Patent: US6586633, 2003, B1,
[3] Recueil des Travaux Chimiques des Pays-Bas, 1926, vol. 45, p. 303
[4] Journal of Organic Chemistry, 1992, vol. 57, # 10, p. 2967 - 2970
[5] American Chemical Journal, 1908, vol. 40, p. 348
[6] Recueil des Travaux Chimiques des Pays-Bas, 1926, vol. 45, p. 303
[7] Journal of Organic Chemistry, 1992, vol. 57, # 10, p. 2967 - 2970
[8] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 19, p. 2903 - 2909
[9] Patent: US5254683, 1993, A,
[10] Patent: US2006/287287, 2006, A1, . Location in patent: Page/Page column 19
[11] Chemical Biology and Drug Design, 2017, vol. 90, # 6, p. 1271 - 1281
  • 4
  • [ 56990-02-4 ]
  • [ 56908-88-4 ]
Reference: [1] Supramolecular Chemistry, 2011, vol. 23, # 6, p. 480 - 485
[2] Chemistry - A European Journal, 2012, vol. 18, # 24, p. 7473 - 7485
  • 5
  • [ 1611-92-3 ]
  • [ 56908-88-4 ]
  • [ 256386-08-0 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 17, p. 5664 - 5670
[2] Tetrahedron Asymmetry, 2010, vol. 21, # 23, p. 2768 - 2774
  • 6
  • [ 56908-88-4 ]
  • [ 145691-59-4 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1926, vol. 45, p. 303
  • 7
  • [ 56908-88-4 ]
  • [ 143-33-9 ]
  • [ 188347-48-0 ]
Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 7, p. 2173 - 2185
  • 8
  • [ 56908-88-4 ]
  • [ 188347-48-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1215 - 1227
  • 9
  • [ 56908-88-4 ]
  • [ 188347-49-1 ]
Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 7, p. 2173 - 2185
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 56908-88-4 ]

Aryls

Chemical Structure| 823-78-9

[ 823-78-9 ]

1-Bromo-3-(bromomethyl)benzene

Similarity: 0.93

Chemical Structure| 589-15-1

[ 589-15-1 ]

1-Bromo-4-(bromomethyl)benzene

Similarity: 0.93

Chemical Structure| 35335-16-1

[ 35335-16-1 ]

1,4-Dibromo-2,5-bis(bromomethyl)benzene

Similarity: 0.91

Chemical Structure| 64382-93-0

[ 64382-93-0 ]

1,2-Dibromo-4-(bromomethyl)benzene

Similarity: 0.91

Chemical Structure| 553-94-6

[ 553-94-6 ]

2,5-Dimethylbromobenzene

Similarity: 0.90

Bromides

Chemical Structure| 823-78-9

[ 823-78-9 ]

1-Bromo-3-(bromomethyl)benzene

Similarity: 0.93

Chemical Structure| 589-15-1

[ 589-15-1 ]

1-Bromo-4-(bromomethyl)benzene

Similarity: 0.93

Chemical Structure| 35335-16-1

[ 35335-16-1 ]

1,4-Dibromo-2,5-bis(bromomethyl)benzene

Similarity: 0.91

Chemical Structure| 64382-93-0

[ 64382-93-0 ]

1,2-Dibromo-4-(bromomethyl)benzene

Similarity: 0.91

Chemical Structure| 553-94-6

[ 553-94-6 ]

2,5-Dimethylbromobenzene

Similarity: 0.90

Benzyl bromides

Chemical Structure| 823-78-9

[ 823-78-9 ]

1-Bromo-3-(bromomethyl)benzene

Similarity: 0.93

Chemical Structure| 589-15-1

[ 589-15-1 ]

1-Bromo-4-(bromomethyl)benzene

Similarity: 0.93

Chemical Structure| 35335-16-1

[ 35335-16-1 ]

1,4-Dibromo-2,5-bis(bromomethyl)benzene

Similarity: 0.91

Chemical Structure| 64382-93-0

[ 64382-93-0 ]

1,2-Dibromo-4-(bromomethyl)benzene

Similarity: 0.91

Chemical Structure| 259231-26-0

[ 259231-26-0 ]

2-Bromo-4-(bromomethyl)-1-methylbenzene

Similarity: 0.90